236 related articles for article (PubMed ID: 27895816)
1. Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer.
Tsuchikawa T; Takeuchi S; Nakamura T; Shichinohe T; Hirano S
World J Gastrointest Oncol; 2016 Nov; 8(11):786-792. PubMed ID: 27895816
[TBL] [Abstract][Full Text] [Related]
2. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting.
Chaudhary B; Elkord E
Vaccines (Basel); 2016 Aug; 4(3):. PubMed ID: 27509527
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and tumor microenvironment of pancreatic cancer.
Liu Q; Liao Q; Zhao Y
Cancer Cell Int; 2017; 17():68. PubMed ID: 28694739
[TBL] [Abstract][Full Text] [Related]
5. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
Darragh LB; Oweida AJ; Karam SD
Front Immunol; 2018; 9():3154. PubMed ID: 30766539
[TBL] [Abstract][Full Text] [Related]
6. Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment.
Belderbos RA; Aerts JGJV; Vroman H
Mol Ther Oncolytics; 2019 Jun; 13():67-81. PubMed ID: 31020037
[TBL] [Abstract][Full Text] [Related]
7. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.
Lu C; Rong D; Zhang B; Zheng W; Wang X; Chen Z; Tang W
Mol Cancer; 2019 Aug; 18(1):130. PubMed ID: 31464625
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor-associated macrophages to combat pancreatic cancer.
Cui R; Yue W; Lattime EC; Stein MN; Xu Q; Tan XL
Oncotarget; 2016 Aug; 7(31):50735-50754. PubMed ID: 27191744
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
10. Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells.
Yong SB; Chung JY; Song Y; Kim J; Ra S; Kim YH
Biomaterials; 2019 Oct; 219():119401. PubMed ID: 31398571
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia.
Ocadlikova D; Lecciso M; Isidori A; Loscocco F; Visani G; Amadori S; Cavo M; Curti A
Front Oncol; 2019; 9():1004. PubMed ID: 31649875
[TBL] [Abstract][Full Text] [Related]
12. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
Bremnes RM; Busund LT; Kilvær TL; Andersen S; Richardsen E; Paulsen EE; Hald S; Khanehkenari MR; Cooper WA; Kao SC; Dønnem T
J Thorac Oncol; 2016 Jun; 11(6):789-800. PubMed ID: 26845192
[TBL] [Abstract][Full Text] [Related]
13. Targeting both tumour-associated CXCR2
Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
[TBL] [Abstract][Full Text] [Related]
14. Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment.
Chen F; Li J; Wang H; Ba Q
Front Oncol; 2021; 11():746917. PubMed ID: 34722304
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic gene modified cell based cancer vaccines.
Kozłowska A; Mackiewicz J; Mackiewicz A
Gene; 2013 Aug; 525(2):200-7. PubMed ID: 23566846
[TBL] [Abstract][Full Text] [Related]
16. [Strategical consideration of the interaction between tumor microenvironment and tumor immunity].
Fujiwara H
Rinsho Ketsueki; 2018; 59(10):1895-1904. PubMed ID: 30305490
[TBL] [Abstract][Full Text] [Related]
17. Tumor Microenvironment as A "Game Changer" in Cancer Radiotherapy.
Jarosz-Biej M; Smolarczyk R; Cichoń T; Kułach N
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261963
[TBL] [Abstract][Full Text] [Related]
18. Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy.
Peng M; Ying Y; Zhang Z; Liu L; Wang W
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173915
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy.
Yin Z; Li C; Wang J; Xue L
Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569
[TBL] [Abstract][Full Text] [Related]
20. Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy.
van Gulijk M; Dammeijer F; Aerts JGJV; Vroman H
Front Immunol; 2018; 9():2759. PubMed ID: 30568653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
